Robin Halter

843 total citations
8 papers, 616 citations indexed

About

Robin Halter is a scholar working on Endocrine and Autonomic Systems, Cognitive Neuroscience and Nutrition and Dietetics. According to data from OpenAlex, Robin Halter has authored 8 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrine and Autonomic Systems, 4 papers in Cognitive Neuroscience and 3 papers in Nutrition and Dietetics. Recurrent topics in Robin Halter's work include Sleep and Wakefulness Research (3 papers), Infant Nutrition and Health (3 papers) and Neuroscience of respiration and sleep (3 papers). Robin Halter is often cited by papers focused on Sleep and Wakefulness Research (3 papers), Infant Nutrition and Health (3 papers) and Neuroscience of respiration and sleep (3 papers). Robin Halter collaborates with scholars based in United States, Belgium and Canada. Robin Halter's co-authors include Kathleen Fitzgerald, Michael B. Montalto, Nancy Auestad, Joan R. Jacobs, Wenzi Qiu, Robert T. Hall, Michael B. Hennessy, David S. Tuber, Deborah Miller and James A. Taylor and has published in prestigious journals such as PEDIATRICS, Psychological Science and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Robin Halter

8 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Halter United States 8 310 132 117 104 92 8 616
Nancy J. Kenney United States 13 86 0.3× 91 0.7× 269 2.3× 33 0.3× 27 0.3× 22 814
Kerstin Uvnäs-Moberg Sweden 9 32 0.1× 46 0.3× 151 1.3× 57 0.5× 13 0.1× 10 593
Eric M. Bomberg United States 19 120 0.4× 65 0.5× 333 2.8× 66 0.6× 54 0.6× 36 994
Heidi M. Rivera United States 15 84 0.3× 181 1.4× 182 1.6× 164 1.6× 34 0.4× 18 718
Sydney Reisbick United States 10 291 0.9× 127 1.0× 68 0.6× 11 0.1× 25 0.3× 15 579
Lauren Williamson United States 12 29 0.1× 97 0.7× 33 0.3× 20 0.2× 66 0.7× 24 766
Roch-Hugo Bouchard Canada 18 30 0.1× 42 0.3× 37 0.3× 80 0.8× 101 1.1× 50 807
S. Hampton United Kingdom 21 84 0.3× 32 0.2× 468 4.0× 89 0.9× 91 1.0× 44 1.2k
Lone Brinkmann Sørensen Denmark 11 301 1.0× 16 0.1× 126 1.1× 29 0.3× 16 0.2× 15 910
Louise Harvey Netherlands 14 58 0.2× 153 1.2× 35 0.3× 41 0.4× 39 0.4× 22 600

Countries citing papers authored by Robin Halter

Since Specialization
Citations

This map shows the geographic impact of Robin Halter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Halter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Halter more than expected).

Fields of papers citing papers by Robin Halter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Halter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Halter. The network helps show where Robin Halter may publish in the future.

Co-authorship network of co-authors of Robin Halter

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Halter. A scholar is included among the top collaborators of Robin Halter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Halter. Robin Halter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Klein, Matthew, Abigail Bangerter, Robin Halter, et al.. (2024). Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study. Neuropsychopharmacology. 50(2). 480–487. 8 indexed citations
2.
Revell, Victoria L., Ciro della Monica, Hana Hassanin, et al.. (2021). Effects of the selective orexin-2 receptor antagonist JNJ-48816274 on sleep initiated in the circadian wake maintenance zone: a randomised trial. Neuropsychopharmacology. 47(3). 719–727. 8 indexed citations
3.
Paulus, Martin P., Murray B. Stein, Alan N. Simmons, et al.. (2020). The effects of FAAH inhibition on the neural basis of anxiety-related processing in healthy male subjects: a randomized clinical trial. Neuropsychopharmacology. 46(5). 1011–1019. 40 indexed citations
4.
Bonaventure, Pascal, Jonathan Shelton, Sujin Yun, et al.. (2015). Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia. Journal of Pharmacology and Experimental Therapeutics. 354(3). 471–482. 71 indexed citations
5.
Auestad, Nancy, David T. Scott, Jeri S. Janowsky, et al.. (2003). Visual, Cognitive, and Language Assessments at 39 Months: A Follow-up Study of Children Fed Formulas Containing Long-Chain Polyunsaturated Fatty Acids to 1 Year of Age. PEDIATRICS. 112(3). e177–e183. 176 indexed citations
6.
Auestad, Nancy, Robin Halter, Robert T. Hall, et al.. (2001). Growth and Development in Term Infants Fed Long-Chain Polyunsaturated Fatty Acids: A Double-Masked, Randomized, Parallel, Prospective, Multivariate Study. PEDIATRICS. 108(2). 372–381. 173 indexed citations
7.
Halter, Robin, et al.. (1999). Formula Tolerance in Postbreastfed and Exclusively Formula-fed Infants. PEDIATRICS. 103(1). e7–e7. 40 indexed citations
8.
Tuber, David S., et al.. (1999). Dogs in Animal Shelters: Problems, Suggestions, and Needed Expertise. Psychological Science. 10(5). 379–386. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy J. Kenney Breakdown of academic impact, for papers by Kerstin Uvnäs-Moberg Breakdown of academic impact, for papers by Eric M. Bomberg Breakdown of academic impact, for papers by Heidi M. Rivera Breakdown of academic impact, for papers by Sydney Reisbick Breakdown of academic impact, for papers by Lauren Williamson Breakdown of academic impact, for papers by Roch-Hugo Bouchard Breakdown of academic impact, for papers by S. Hampton Breakdown of academic impact, for papers by Lone Brinkmann Sørensen Breakdown of academic impact, for papers by Louise Harvey
Rankless by CCL
2026